Clinical trials
HIV/AIDS clinical trials
Below are recruiting hiv/aids clinical trials, each written for real people, not researchers. We’re tracking 37 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06462807Recruiting
Improving HIV care in Philadelphia clinics
This study looks at how to improve HIV care and viral suppression by making the clinic environment better for both patients and staff. It may help you stay in care and keep your viral load undetectable.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06472206Recruiting
HIV support with a health coach and smartphone app
This study is testing a program that pairs you with a community health worker and a smartphone app to help get your HIV under control. It is for people whose virus is not fully suppressed and who live in certain Southern states.
Hobson City, AlabamaAges 18 years+ - NCT06480578RecruitingPhase 2
Sensor pill study to improve HIV medication adherence
This study tests a special pill that has a sensor inside, which sends information to your doctor or care team to help you remember to take your HIV medication. It is for people who sometimes miss doses and want extra support.
Los Angeles, CaliforniaAges 18 years+ - NCT06528626Recruiting
Screening tool for HIV and hepatitis C
This study is testing a tool to find people who may be at risk for or already have HIV or hepatitis C. It aims to connect them with care and support.
Madrid, MadridAges 14–65 - NCT06566430Recruiting
PrEP My Way: Helping young women stay on PrEP
This study tests whether a program called 'PrEP My Way' can help young women in Kenya stick with taking PrEP pills to prevent HIV. It's designed for women ages 16–24 who are just starting PrEP in Kisumu County.
KisumuAges 16–24 - NCT06741618Recruiting
HIV prevention study for young men
This study tests a mobile app to help young men who have sex with men stay HIV-negative. It focuses on people who have had condomless anal sex recently and are not using PrEP.
New York, New YorkAges 16–25 - NCT06741631Recruiting
Mobile app to help young men reduce HIV risk
This trial tests a mobile app designed to help young men who have sex with men (and non-binary people assigned male at birth) reduce their risk of HIV. It's for people who are HIV-negative or don't know their status, and who have had anal sex with a partner with a penis in the last year.
Chicago, IllinoisAges 16–29 - NCT06856174RecruitingPhase 4
Menopause Hormone Therapy for Women with HIV
This trial tests whether hormone therapy can help manage hot flashes and night sweats in women living with HIV who are going through menopause. It's designed to see if this treatment is safe and effective for this group.
Birmingham, AlabamaAges 40–60 - NCT06949774Recruiting
Text reminders to help with HIV medication adherence
This study tests whether daily text message reminders and a small tracking device (WisePill) can help people who recently started HIV medication stay on track. It's designed for people who began treatment in the past 2 months and are willing to receive texts and use the device.
KampalaAges 18 years+ - NCT07118683Recruiting
Brazilian health study for people with HIV or AIDS
This study is creating a record of chronic health conditions (like heart disease, diabetes, or high blood pressure) in people living with HIV or AIDS in Brazil. Joining helps researchers better understand and care for the health needs of people like you.
Goiânia, GoiásAges 18 years+ - NCT07298785Recruiting
HIV prevention study led by peers for women
This study tests a peer-led approach to HIV prevention for women. It looks at whether having a peer (someone like you) help choose and use prevention tools can work better than standard care.
KampalaAges 15 years+ - NCT03240328RecruitingPhase 1
CAR-T therapy study for rebuilding HIV immune defenses
This early-stage study tests whether CAR-T cells can help rebuild the immune system’s ability to fight HIV. You may be a candidate if your HIV is well controlled on standard treatment and you don’t have certain serious infections or organ problems.
Guangzhou, GuangdongAges 18–60 - NCT03856229Enrolling by invitation
Short steroid treatment for lung infection from PCP in HIV
This study tests whether short-term steroid treatment helps adults with a specific lung infection (PCP) that happens with HIV/AIDS. It compares outcomes in people who start steroids soon after admission while also taking standard PCP antibiotics.
México, State of MexicoAges 18–80
Hear when a new HIV/AIDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hiv/aids?
- Yes. Clin2 currently lists 37 recruiting hiv/aids studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hiv/aids trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hiv/aids trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.